IWA
ANIK icon

Intercontinental Wealth Advisors’s Anika Therapeutics ANIK Stock Holding History

Intercontinental Wealth Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,257
Closed -$318K – 266
2022
Q2 		$318K Hold
14,257
– – 0.09% 218
2022
Q1 		$358K Sell
14,257
-730
-5% -$22.3K 0.08% 216
2021
Q4 		$537K Sell
14,987
-188
-1% -$7.53K 0.11% 173
2021
Q3 		$646K Sell
15,175
-759
-5% -$31.3K 0.15% 137
2021
Q2 		$690K Buy
15,934
+88
+0.6% +$3.75K 0.14% 125
2021
Q1 		$646K Buy
15,846
+239
+2% +$9.07K 0.14% 125
2020
Q4 		$706K Buy
15,607
+77
+0.5% +$2.92K 0.17% 111
2020
Q3 		$550K Buy
15,530
+308
+2% +$11.1K 0.16% 106
2020
Q2 		$574K Buy
15,222
+2,754
+22% +$90.7K 0.19% 95
2020
Q1 		$360K Buy
+12,468
New +$504K 0.19% 103

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Intercontinental Wealth Advisors's ANIK Position: Q3 2022 in Review

Intercontinental Wealth Advisors sold out of Anika Therapeutics (ANIK) in Q3 2022, closing a stake of 14,257 shares — an estimated $318K sold.

Intercontinental Wealth Advisors first reported a position in ANIK in Q1 2020 and held it in 10 quarters. The position peaked at $706K in Q4 2020. 121 funds tracked by Wall St. Rank hold ANIK as of Q3 2022.

  • Intercontinental Wealth Advisors reported no remaining Anika Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 14,257 Anika Therapeutics shares in Q3 2022, an estimated $318K.
  • Intercontinental Wealth Advisors first reported a position in Anika Therapeutics in Q1 2020 and held it in 10 quarters.
  • Intercontinental Wealth Advisors's Anika Therapeutics position peaked at $706K in Q4 2020.
  • 121 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2022.

Based on Intercontinental Wealth Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.